» Articles » PMID: 20080565

G Protein-coupled Receptor Kinase 2 (GRK2) Modulation and Cell Cycle Progression

Overview
Specialty Science
Date 2010 Jan 19
PMID 20080565
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Cell cycle progression requires changes in the activity or levels of a variety of key signaling proteins. G protein-coupled receptor kinase 2 (GRK2) plays a central role in G protein-coupled receptor regulation. Recent research is uncovering its involvement in additional cellular functions, but the potential role of GRK2 in the cell cycle has not been addressed. We report that GRK2 protein levels are transiently down-regulated during the G2/M transition by a mechanism involving CDK2-mediated phosphorylation of GRK2 at Serine670, which triggers binding to the prolyl-isomerase Pin1 and subsequent degradation. Prevention of GRK2 phosphorylation at S670 impedes normal GRK2 down-regulation and markedly delays cell cycle progression. Interestingly, we find that endogenous GRK2 down-regulation is prevented on activation of the G2/M checkpoint by doxorubicin and that stabilized GRK2 levels in such conditions inversely correlate with the p53 response and the induction of apoptosis, suggesting that GRK2 participates in the regulatory network controlling cell cycle arrest and survival in such conditions.

Citing Articles

GRK2-mediated AKT activation controls cell cycle progression and G2 checkpoint in a p53-dependent manner.

Rivas V, Gonzalez-Munoz T, Albitre A, Lafarga V, Delgado-Arevalo C, Mayor Jr F Cell Death Discov. 2024; 10(1):385.

PMID: 39198399 PMC: 11358448. DOI: 10.1038/s41420-024-02143-8.


Pin1-catalyzed conformational regulation after phosphorylation: A distinct checkpoint in cell signaling and drug discovery.

Lu K, Zhou X Sci Signal. 2024; 17(841):eadi8743.

PMID: 38889227 PMC: 11409840. DOI: 10.1126/scisignal.adi8743.


Pin1-Catalyzed Conformation Changes Regulate Protein Ubiquitination and Degradation.

Jeong J, Usman M, Li Y, Zhou X, Lu K Cells. 2024; 13(9.

PMID: 38727267 PMC: 11083468. DOI: 10.3390/cells13090731.


Exploring the potential biological function of GRK2 in colorectal cancer.

Gao M, Liang X, Fan M, Wu Y, Dong M, Du R Funct Integr Genomics. 2024; 24(2):51.

PMID: 38446273 DOI: 10.1007/s10142-024-01322-1.


Ubiquitination of GRK2 Is Required for the β-Arrestin-Biased Signaling Pathway of Dopamine D2 Receptors to Activate ERK Kinases.

Liu H, Ma H, Zeng X, Wu C, Acharya S, Sudan S Int J Mol Sci. 2023; 24(12).

PMID: 37373182 PMC: 10298151. DOI: 10.3390/ijms241210031.


References
1.
Bliziotes M, GUNNESS M, Zhang X, Nissenson R, Wiren K . Reduced G-protein-coupled-receptor kinase 2 activity results in impairment of osteoblast function. Bone. 2000; 27(3):367-73. DOI: 10.1016/s8756-3282(00)00338-0. View

2.
Metaye T, Gibelin H, Perdrisot R, Kraimps J . Pathophysiological roles of G-protein-coupled receptor kinases. Cell Signal. 2005; 17(8):917-28. DOI: 10.1016/j.cellsig.2005.01.002. View

3.
Bernis C, Vigneron S, Burgess A, Labbe J, Fesquet D, Castro A . Pin1 stabilizes Emi1 during G2 phase by preventing its association with SCF(betatrcp). EMBO Rep. 2006; 8(1):91-8. PMC: 1796751. DOI: 10.1038/sj.embor.7400853. View

4.
Lu K, Zhou X . The prolyl isomerase PIN1: a pivotal new twist in phosphorylation signalling and disease. Nat Rev Mol Cell Biol. 2007; 8(11):904-16. DOI: 10.1038/nrm2261. View

5.
Ho J, Cocolakis E, Dumas V, Posner B, Laporte S, Lebrun J . The G protein-coupled receptor kinase-2 is a TGFbeta-inducible antagonist of TGFbeta signal transduction. EMBO J. 2005; 24(18):3247-58. PMC: 1224684. DOI: 10.1038/sj.emboj.7600794. View